Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.
Neural progenitor cell grafting is a promising therapeutic option in the treatment of Parkinson's disease. In previous experiments we grafted temperature-sensitive immortalized CSM14.1 cells, derived from the ventral mesencephalon of E14-rats, bilaterally in the caudate putamen of adult hemiparkinsonian rats. In these studies we were not able to demonstrate either a therapeutic improvement or neuronal differentiation of transplanted cells. Here we examined whether CSM14.1 cells grafted bilaterally orthotopically in the substantia nigra of hemiparkinsonian rats have the potential to differentiate into dopaminergic neurons. Adult male rats received 6-hydroxydopamine into the right medial forebrain bundle, and successful lesions were evaluated with apomorphine-induced rotations 12 days after surgery. Two weeks after a successful lesion the animals received bilateral intranigral grafts consisting of either about 50 000 PKH26-labelled undifferentiated CSM14.1 cells (n = 16) or a sham-graft (n = 9). Rotations were evaluated 3, 6, 9 and 12 weeks post-grafting. Animals were finally perfused with 4% paraformaldehyde. Cryoprotected brain slices were prepared for immunohistochemistry using the freeze-thaw technique to preserve PKH26-labelling. Slices were immunostained against neuronal epitopes (NeuN, tyrosine hydroxylase) or glial fibrillary acidic protein. The CSM14.1-cell grafts significantly reduced the apomorphine-induced rotations 12 weeks post-grafting compared to the sham-grafts (P < 0.05). There was an extensive mediolateral migration (400-700 microm) of the PKH26-labelled cells within the host substantia nigra. Colocalization with NeuN or glial fibrillary acidic protein in transplanted cells was confirmed with confocal microscopy. No tyrosine hydroxylase-immunoreactive grafted cells were detectable. The therapeutic effect of the CSM14.1 cells could be explained either by their glial cell-derived neurotrophic factor-expression or their neural differentiation with positive effects on the basal ganglia neuronal networks.
Haas
Stefan Jean-Pierre
SJ
Institute of Anatomy, University of Rostock, Germany.
Petrov
Stanislav
S
Kronenberg
Golo
G
Schmitt
Oliver
O
Wree
Andreas
A
D000818:Animals; D016380:Brain Tissue Transplantation / Q000379:methods*; D002452:Cell Count; D002454:Cell Differentiation; D002461:Cell Line, Transformed; D007150:Immunohistochemistry; D008297:Male; D008636:Mesencephalon / Q000473:pathology* / Q000637:transplantation; D008856:Microscopy, Fluorescence; D023421:Models, Animal; D009043:Motor Activity; D039902:Multipotent Stem Cells / Q000637:transplantation*; D009474:Neurons / Q000737:chemistry / Q000473:pathology; D020734:Parkinsonian Disorders / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D011134:Polysaccharides / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D013194:Staining and Labeling; D013378:Substantia Nigra / Q000473:pathology*; D014184:Transplantation, Homologous
D011134:Polysaccharides; C010491:neurotropin